Big Pharma accused of ‘endless talk, no action’ on antibiotic threat

Former head of UK review has also called for a new government-utility-type drug company
Reuters Health

The pharmaceutical industry should match its words with action on researching new antibiotics to address the threat posed by drug-resistant superbugs, a former UK Government adviser says.

In a strongly worded attack on major drug companies, Lord Jim O’Neill, who headed a UK Government review of antimicrobial resistance in 2016, said the industry had produced “endless talk and no action” about the problem.